Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +971 (0) 4 368 1644
  • GDPR
  • Journalists
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +971 (0) 4 368 1644 from 8 AM - 5:30 PM GMT

    • Contact
    • Contact

      +971 (0) 4 368 1644
      from 8 AM - 5:30 PM GMT

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Mindray Launches New MC-80 Automated Digital Cell Morphology Analyzer, Taking Morphology Analysis to the Next Level
  • Latin America - español
  • Brazil - Português


News provided by

Mindray

27 Sep, 2021, 08:20 GMT

Share this article

Share toX

Share this article

Share toX

SHENZHEN, China, Sept. 27, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading medical solution provider, has launched the new MC-80 Automated Digital Cell Morphology Analyzer, a revolutionary cell morphology system that provides more clarity, more intelligence and more productivity for morphological analysis. Combining MC-80, Mindray's hematology solution will revolutionize the high-end hematology segment.

Continue Reading
Mindray MC-80 Digital Cell Morphology Analyzer provides more for morphology analysis.
Mindray MC-80 Digital Cell Morphology Analyzer provides more for morphology analysis.

Morphological review of blood cells is a crucial procedure following hematology analysis. Most laboratories need to re-examine more than 30% of their blood samples, but find traditional microscopic review labor-intensive and time-consuming. Automated digital cell morphology analyzers are now available on the market, but providing clear and accurate cell images comparable to the microscope remains a fundamental challenge.

Mindray's new MC-80 is taking digital morphology analysis to the next level, delivering clearer images which are able to capture abnormalities in more detail. With advanced algorithms, the analyzer enables better identification of different cells with high throughput, resulting in greater productivity.

"We have spent eight years developing and optimizing the product by collaborating with over 200 top hospitals worldwide. Meanwhile, we have applied for over 100 patents and solved many problems, some of which had been considered insurmountable in automated digital cell morphology analysis," commented Huan Qi, Director of Clinical Research, Medical Affairs; and Director of Upstream Marketing, IVD, Mindray.

The MC-80 provides more in morphology

More Clarity

Equipped with advanced multi-layer fusion technology, the MC-80 reproduces the pathological features of cells with clear and authentic images, which helps pathologists to detect abnormal cells more easily and make a quicker diagnosis.

More Intelligence

The MC-80 facilitates a smart process and less manual intervention by analyzing the smear in an optimal mode according to the results from hematology analyzers. Its advanced algorithms offer reliable cell pre-classification and pre-characterization, and the high-speed FLY-MODE ensures fast and accurate PLT clump identification.

More Productivity

With the remote review function, pathologists are able to review results from multiple locations. The high throughput of 60 samples per hour helps shorten the turnaround time, especially for large-sized laboratories. This greatly enhances diagnostic efficiency and ensures a faster delivery of results to patients.

Mindray always provides high quality, reliable IVD solutions to empower trust, delivering accurate results while meeting laboratories' demands on efficiency worldwide.

Learn more about MC-80:
https://www.mindray.com/en/product/MC_80.html

Watch the launch event:
https://www.mindray.com/en/static/webinar?live=mc80launch

Photo - https://mma.prnewswire.com/media/1634129/image1.jpg 

Modal title

Also from this source

Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025

Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025

Mindray (SZSE: 300760), a leading global developer of healthcare technologies, launched its BeneVision V Series patient monitoring solution at...

المزيد من الإصدارات من هذا المصدر

Explore

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

New Products & Services

New Products & Services

المزيد من البيانات الصحفية في مواضيع ذات صلة

Contact PR Newswire

  • +971 (0) 4 368 1644
    from 8 AM - 5:30 PM GMT

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+971 (0) 4 368 1644
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.